European Economic
and Social Committee
Pharmaceutical package
Background
The pharmaceutical industry is one of the largest and most economically important industries in the European Union, employing around 840 000 people directly and generating three times as much employment indirectly. In 2021, the industry invested an estimated EUR 41 billion in research and innovation.
This opinion from the European Economic and Social Committee covers the proposed revision of EU pharmaceuticals legislation and sets out measures to address antimicrobial resistance in the EU.
Overall, the EESC is very supportive of this long-awaited revamp and backs the European Commission's twin goal of making medicines more affordable and readily available while also ensuring that the industry remains competitive and attracts investment. The measures the EESC suggests embrace this spirit, aiming to maximise benefits for both patients and industry.
Key points
The EESC suggests:
- making more use of joint purchasing of medicines, which can take many shapes, to help ensure access to affordable treatment, which remain an issue;
- setting up a special EU-level fund to ensure access to treatment for all patients in Europe suffering from rare diseases, taking into account disparities in healthcare provision between Member States, such as when statutory health insurance does not cover the entire cost of treatment;
- offering incentives to favour drug manufacturers in the EU and encourage the relocation of production from non-EU countries in order to mitigate dependencies. It also proposes the establishment of a European contingency reserve of medicines of strategic importance.
Additional information
EESC section responsible: Single Market, Production and Consumption (INT)
Opinion type: mandatory consultation
Rapporteur: Martin SCHAFFENRATH (Civil Society Organisations – AT)
References: COM(2023) 190 final COM(2023) 191 final 2023/0125 NLECOM(2023) 191 final 2023/0125 NLECOM(2023) 192 final 2023/0132 CODCOM(2023) 192 final 2023/0132 CODCOM(2023) 193 final 2023/0131 CODCOM(2023) 193 final 2023/0131 COD
Date of adoption by section: 03/10/2023
Result of the vote: 80 votes in favour, none against, with no abstentions.
Contacts
Daniela MARANGONIPress officer
Tel.: + 32 2 546 8422 | Mob: +32 475 99 94 32
email: daniela.marangoni@eesc.europa.eu
Radoslava STEFANKOVA
Policy officer
Tel.: +32 2 546 8188
Recommended for you
Tetyana Ogarkova: "The day of victory will come but it will not bring normality back"
Agenda
On 24 February 2022, the lives of millions of Ukrainians were turned upside down. Now, when we say the word "victory", we expect that day to be the way things used to be. A normal day, a day of peace…
Lutte contre la précarité énergétique: garantir un approvisionnement énergétique abordable devrait figurer au premier rang des priorités politiques des pays de l’UE
News
Alors que le nombre de ménages qui sont dans l’incapacité de chauffer leur logement va vraisemblablement augmenter dans l’Union, avec une inflation annuelle de l’énergie qui dépasse 40 %, il y a…
Les zones rurales ont le potentiel pour produire davantage de résultats
News
Si l’attrait de la vie à la campagne s’est accru ces toutes dernières années, de nombreuses zones rurales de l’Union restent confrontées à un certain nombre de problèmes qui dissuadent les personnes…
Pour lutter contre le sans-abrisme, il faut une approche globale et une action collective
News
Le 7 octobre dernier, le Comité économique et social européen (CESE) a tenu une conférence sur le sans-abrisme et les moyens d’éradiquer ce phénomène d’ici à 2030, en appliquant le principe du…
Un rôle actif pour la société civile organisée est essentiel à la résilience de l’Union européenne
News
Le CESE a tenu un débat en session plénière sur l’importance croissante de la société civile organisée et des villes pour mettre l’Europe en capacité de faire face aux chocs asymétriques et aux…